ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2014

The SGLT2 Inhibitor Empagliflozin for the Treatment of Type 2 Diabetes Mellitus: a Bench to Bedside Review.

Janet B McGillPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.